Ken Griffin Albemarle Corp Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$72.85 - $100.09 $4.06 Million - $5.58 Million	-55,700 Reduced 3.62%	1,485,000 $141 Million
Q2 2024 Aug 14, 2024	BUY	$92.77 - $135.46 $11 Million - $16 Million	118,300 Added 8.32%	1,540,700 $147 Million
Q1 2024 May 15, 2024	BUY	$108.73 - $146.89 $15.3 Million - $20.6 Million	140,400 Added 10.95%	1,422,400 $187 Million
Q4 2023 Feb 14, 2024	BUY	$113.26 - $170.8 $61.9 Million - $93.4 Million	546,700 Added 74.35%	1,282,000 $185 Million
Q3 2023 Nov 14, 2023	BUY	$162.63 - $243.44 $26.7 Million - $39.9 Million	163,900 Added 28.68%	735,300 $125 Million
Q2 2023 Aug 14, 2023	SELL	$172.91 - $232.22 $32.3 Million - $43.4 Million	-187,000 Reduced 24.66%	571,400 $127 Million
Q1 2023 May 15, 2023	BUY	$208.49 - $290.15 $83 Million - $115 Million	398,000 Added 110.43%	758,400 $168 Million
Q4 2022 Feb 14, 2023	SELL	$214.02 - $325.38 $13.7 Million - $20.8 Million	-64,000 Reduced 15.08%	360,400 $78.1 Million
Q3 2022 Nov 14, 2022	BUY	$195.82 - $307.05 $9.28 Million - $14.6 Million	47,400 Added 12.57%	424,400 $112 Million

927

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $10.5B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.